Summary:
A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Inhaler and a Symbicort Reference Inhaler, Each Delivering Budesonide/Formoterol Fumarate (80ug/4.5ug) in Adult Subjects with Asthma
Qualified Participants Must:
• Currently be nonsmoking including E-cigarettes within the past year and has less than 10 pack-years of historical use
•
Be Male or Female older than 18 years of age
•
If female of childbearing potential and committed to consistent and correct use of an acceptable method of birth control
•
Have been diagnosed by physician of Asthma at least 6 months prior to screening for study participation
•
Have stable asthma control on chronic asthma treatment regimen for at least 4 weeks prior to study visit
Qualified Participants May Receive:
$300-$500+ compensation, free treatment and doctor consultations with 24hr emergency phone line